Pharma Sector
Advertisement
Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY
"We have had a strong start to the year. At a consolidated level, revenues rose 59 per cent YoY to Rs 3,516 crore driven primarily by the 106 per cent jump in biosimilars revenue. Research services revenue rose 25 per cent, and Generics reported 15 per cent growth.
Advertisement